Colleges
Junqing Xie
B.S.Med, MSc, DPhil
- Postdoctoral Researcher
- Extraordinary Junior Research Fellow in Clinical Sciences
Pharmacoepidemiology, Pharmacogenomics, Precision Medicine
I specialise in studying drugs&vaccines effects, and understanding interplays between major communicable or non-communicable diseases via modern population-based research techniques.
Prior to my role at NDORMS, I was a statistical programming training fellow (2018-2019) at the Oxford Big Data Institute, where I gained a systematic training in developing well-organised analytic pipelines for large-scale research initiatives.
I also received medical training at Shandong University (Bachelor 2015), Epidemiology and Biostatistics at Peking University (MSc 2018) in China, and Clinical Epidemiology at Oxford University (DPhil 2023).
Key publications
-
Association of Tramadol vs Codeine Prescription Dispensation With Mortality and Other Adverse Clinical Outcomes.
Journal article
Xie J. et al, (2021), Jama, 326, 1504 - 1515
-
Clinical and Genetic Risk Factors for Acute Incident Venous Thromboembolism in Ambulatory Patients With COVID-19.
Journal article
Xie J. et al, (2022), Jama intern med
-
Comparative effectiveness of the BNT162b2 and ChAdOx1 vaccines against Covid-19 in people over 50.
Journal article
Xie J. et al, (2022), Nat commun, 13
-
Genetic risk, adherence to healthy lifestyle and acute cardiovascular and thromboembolic complications following SARS-COV-2 infection.
Journal article
Xie J. et al, (2023), Nat commun, 14
-
Relationship between HLA genetic variations, COVID-19 vaccine antibody response, and risk of breakthrough outcomes.
Journal article
Xie J. et al, (2024), Nat commun, 15
-
Long-term risk of psychiatric disorder and psychotropic prescription after SARS-CoV-2 infection among UK general population.
Journal article
Wang Y. et al, (2024), Nat hum behav
-
Modifiable lifestyle factors and the risk of post-COVID-19 multisystem sequelae, hospitalization, and death.
Journal article
Wang Y. et al, (2024), Nat commun, 15
-
Hospitalization for COVID-19, Other Respiratory Infections, and Postacute Patient-Reported Symptoms.
Journal article
Gao Y. et al, (2024), Jama netw open, 7
-
Incidence of post-acute COVID-19 symptoms across healthcare settings in seven countries: an international retrospective cohort study using routinely-collected data.
Journal article
Xie J. et al, (2024), Eclinicalmedicine, 77
-
Refinement of post-COVID condition core symptoms, subtypes, determinants, and health impacts: a cohort study integrating real-world data and patient-reported outcomes.
Journal article
Wang Y. et al, (2025), Ebiomedicine, 111
Recent publications
-
Independent and combined effects of long-term air pollution exposure and genetic predisposition on COVID-19 severity: A population-based cohort study.
Journal article
Ma Y. et al, (2025), Proc natl acad sci u s a, 122
-
Immunity debt for seasonal influenza after the COVID-19 pandemic and as a result of non-pharmaceutical interventions: an ecological analysis and cohort study
Journal article
Chen L. et al, (2025), Advanced science
-
Hospital-Treated Infections and 15-year Incidence of Musculoskeletal Disorders: A Large Population-Based Cohort Study.
Journal article
Gao Y. et al, (2025), Clin epidemiol, 17, 251 - 264
-
Refinement of post-COVID condition core symptoms, subtypes, determinants, and health impacts: a cohort study integrating real-world data and patient-reported outcomes.
Journal article
Wang Y. et al, (2025), Ebiomedicine, 111
-
PDE5 inhibition and Alzheimer’s disease risk: a mendelian randomisation study
Preprint
Alcalde-Herraiz M. et al, (2024)
-
Effect of genetically predicted sclerostin on cardiovascular biomarkers, risk factors, and disease outcomes.
Journal article
Alcalde-Herraiz M. et al, (2024), Nat commun, 15
-
Incidence of post-acute COVID-19 symptoms across healthcare settings in seven countries: an international retrospective cohort study using routinely-collected data.
Journal article
Xie J. et al, (2024), Eclinicalmedicine, 77
-
Long-term exposure to fine particulate matter constituents, genetic susceptibility, and incident heart failure among 411 807 adults.
Journal article
Cui F. et al, (2024), Eur j heart fail
-
Cohort Profile: The Xiangya Osteoarthritis (XO) Study.
Journal article
Li J. et al, (2024), Int j epidemiol, 53
-
Genome-wide association studies of COVID-19 vaccine seroconversion and breakthrough outcomes in UK Biobank.
Journal article
Alcalde-Herraiz M. et al, (2024), Nat commun, 15